137 related articles for article (PubMed ID: 16370198)
1. [New epidemiologic data show: conventional NSAIDs need individual benefit-risk evaluation].
MMW Fortschr Med; 2005 Nov; 147(47):62-3. PubMed ID: 16370198
[No Abstract] [Full Text] [Related]
2. Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction.
Gislason GH; Jacobsen S; Rasmussen JN; Rasmussen S; Buch P; Friberg J; Schramm TK; Abildstrom SZ; Køber L; Madsen M; Torp-Pedersen C
Circulation; 2006 Jun; 113(25):2906-13. PubMed ID: 16785336
[TBL] [Abstract][Full Text] [Related]
3. Association between nonnaproxen NSAIDs, COX-2 inhibitors and hospitalization for acute myocardial infarction among the elderly: a retrospective cohort study.
Rahme E; Watson DJ; Kong SX; Toubouti Y; LeLorier J
Pharmacoepidemiol Drug Saf; 2007 May; 16(5):493-503. PubMed ID: 17086567
[TBL] [Abstract][Full Text] [Related]
4. The COX-2 controversy continues ...but NSAIDs are still in the lead. New studies shed light on risks associated with popular arthritis painkillers.
Health News; 2006 Aug; 12(8):3-4. PubMed ID: 16913025
[No Abstract] [Full Text] [Related]
5. Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study.
Rahme E; Nedjar H
Rheumatology (Oxford); 2007 Mar; 46(3):435-8. PubMed ID: 17255138
[TBL] [Abstract][Full Text] [Related]
6. [Study results of routine clinical practice. Do rheumatism patients get substandard care?].
MMW Fortschr Med; 2005 Nov; 147(47):63. PubMed ID: 16370199
[No Abstract] [Full Text] [Related]
7. [Overestimated].
Höer A; Häussler B
Med Klin (Munich); 2006 Aug; 101(8):676-7; author reply 678-9. PubMed ID: 17051671
[No Abstract] [Full Text] [Related]
8. The balance between severe cardiovascular and gastrointestinal events among users of selective and non-selective non-steroidal anti-inflammatory drugs.
van der Linden MW; van der Bij S; Welsing P; Kuipers EJ; Herings RM
Ann Rheum Dis; 2009 May; 68(5):668-73. PubMed ID: 18495734
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous assessment of short-term gastrointestinal benefits and cardiovascular risks of selective cyclooxygenase 2 inhibitors and nonselective nonsteroidal antiinflammatory drugs: an instrumental variable analysis.
Schneeweiss S; Solomon DH; Wang PS; Rassen J; Brookhart MA
Arthritis Rheum; 2006 Nov; 54(11):3390-8. PubMed ID: 17075817
[TBL] [Abstract][Full Text] [Related]
10. Balancing the cyclooxygenase portfolio.
Armstrong PW
CMAJ; 2006 May; 174(11):1581-2. PubMed ID: 16717266
[No Abstract] [Full Text] [Related]
11. The Vioxx fallout.
Palmer K
Minn Med; 2005 Mar; 88(3):26-30. PubMed ID: 15852592
[No Abstract] [Full Text] [Related]
12. Coxibs, non-steroidal anti-inflammatory drugs and cardiovascular risk.
Hermann M; Ruschitzka F
Intern Med J; 2006 May; 36(5):308-19. PubMed ID: 16650196
[TBL] [Abstract][Full Text] [Related]
13. [Drug safety of NSAIDs and COX-2 inhibitors].
Herdegen T; Fauler J
Med Monatsschr Pharm; 2006 Apr; 29(4):122-8. PubMed ID: 16628961
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 inhibitors and most traditional nonsteroidal anti-inflammatory drugs cause similar moderately increased risks of cardiovascular disease.
Hennekens CH; Borzak S
J Cardiovasc Pharmacol Ther; 2008 Mar; 13(1):41-50. PubMed ID: 18287589
[TBL] [Abstract][Full Text] [Related]
15. NSAID use and the risk of hospitalization for first myocardial infarction in the general population: a nationwide case-control study from Finland.
Helin-Salmivaara A; Virtanen A; Vesalainen R; Grönroos JM; Klaukka T; Idänpään-Heikkilä JE; Huupponen R
Eur Heart J; 2006 Jul; 27(14):1657-63. PubMed ID: 16731535
[TBL] [Abstract][Full Text] [Related]
16. Use of first- and second-generation cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs and risk of acute myocardial infarction.
Andersohn F; Suissa S; Garbe E
Circulation; 2006 Apr; 113(16):1950-7. PubMed ID: 16618816
[TBL] [Abstract][Full Text] [Related]
17. NSAIDS and the risk of myocardial infarction: do they help or harm?
Bhatt DL
Eur Heart J; 2006 Jul; 27(14):1635-6. PubMed ID: 16782714
[No Abstract] [Full Text] [Related]
18. Does the varied use of NSAIDs explain the differences in the risk of myocardial infarction?
van Staa TP; Rietbrock S; Setakis E; Leufkens HG
J Intern Med; 2008 Nov; 264(5):481-92. PubMed ID: 18624902
[TBL] [Abstract][Full Text] [Related]
19. Etoricoxib: new drug. Avoid using cox-2 inhibitors for pain.
Prescrire Int; 2007 Dec; 16(92):223-7. PubMed ID: 18084859
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of diclofenac or other non-steroidal anti-inflammatory drugs (NSAIDs) and diclofenac or other NSAIDs in combination with proton pump inhibitors (PPI) on hospitalisation due to peptic ulcer disease.
Höer A; Gothe H; Schiffhorst G; Sterzel A; Grass U; Häussler B
Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):854-8. PubMed ID: 17323403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
